Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 71335-0308

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 71335-0308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Carvedilol 1)

Chemical structure of carvedilol phosphate, showing the detailed molecular arrangement including aromatic rings, nitrogen, oxygen atoms, and phosphate and water components indicated as H3PO4 and 1/2 H2O.*

FDA Label Image

Figure (Carvedilol 2)

Two line graphs showing the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 24 hours after a morning dose of carvedilol phosphate extended-release capsules in 20 mg, 40 mg, and 80 mg strengths. The graphs depict time on the x-axis and blood pressure change on the y-axis, with smoothed lines for each dosage level.*

FDA Label Image

Label (Lbl713350308)

Label for Carvedilol Phosphate Extended-Release Capsules 10 mg, repackaged by Bryant Ranch Prepack and manufactured by Frontida BioPharm. The label includes the NDC 71335-0308-1, package size of 30 capsules, storage instructions at 25°C (77°F), and warnings about membrane seal integrity and overdose emergency guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.